Dosage
Your doctor will prescribe your dosage based on the following factors:
- Your overall health
- Whether you’ve been on insulin before or are switching from another type of insulin to Tresiba
- The type of diabetes you have
- Other drugs you’re taking
- Your weight
Tresiba is available as refilled injection pens in two strengths. It can also come in multiple-dose insulin vials used with different insulin syringes. It is important to check whether the dosage of the drug is correct.
If you have used insulin before, your doctor will prescribe a low dose for you. Your doctor will change your dose slowly until your blood glucose level returns to normal. There is no limit to the amount of insulin you can take in a day.
For adults and children using tresiba for the first time, the starting dose will be one-third to one-half of your normal daily dose. The dose depends on the weight of the person. Your doctor adjusts the dose to once a day after a few days.
For children older than 1 year old, the starting dose is usually 80 percent of the total daily dose. The dose will be adjusted regularly until the blood glucose level returns to normal.
For adults who are not taking tresiba for the first time, the starting dose is the same as the total daily dose.
Conclusion
Tresiba is a prescription drug used to treat type 1 and type 2 diabetes. It works by acting like a long-lasting insulin to reduce blood glucose level. The drug is administered through the skin and the drug is absorbed into the blood. Some of its side effects may go away after a few days or some weeks. Contact your healthcare provider if a side effect persists or worsens over time.
Reference:
[1] https://www.who.int/news-room/fact-sheets/detail/diabetes
[2] https://www.webmd.com/digestive-disorders/digestive-diseases-diarrhea
[3] https://my.clevelandclinic.org/health/diseases/9815-hyperglycemia-high-blood-sugar
[4] https://www.healthline.com/health/acute-upper-respiratory-infection
[5] https://www.cdc.gov/diabetes/basics/low-blood-sugar.html
[6] https://emedicine.medscape.com/article/242008-overview